Fri, February 17, 2023
Thu, February 16, 2023
Wed, February 15, 2023

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $23 on, Feb 16th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-23-on-feb-16th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $23 on, Feb 16th, 2023.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, all agrees with Raghuram's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Chris Howerton of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $10 on, Wednesday, February 8th, 2023

Publication Contributing Sources